Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -352.03 |
| peg ratio | 46.86 |
| price to book ratio | -1.80 |
| price to sales ratio | 0.52 |
| enterprise value multiple | -0.23 |
| price fair value | -1.80 |
profitability ratios | |
|---|---|
| gross profit margin | 43.48% |
| operating profit margin | -43.04% |
| pretax profit margin | -0.15% |
| net profit margin | -0.15% |
| return on assets | -0.09% |
| return on equity | 0.4% |
| return on capital employed | -62.54% |
liquidity ratio | |
|---|---|
| current ratio | 1.25 |
| quick ratio | 1.09 |
| cash ratio | 0.33 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 101.09 |
| operating cycle | 339.51 |
| days of payables outstanding | 46.45 |
| cash conversion cycle | 293.06 |
| receivables turnover | 1.53 |
| payables turnover | 7.86 |
| inventory turnover | 3.61 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.46 |
| debt equity ratio | -2.63 |
| long term debt to capitalization | 1.61 |
| total debt to capitalization | 1.61 |
| interest coverage | -4.04 |
| cash flow to debt ratio | -0.27 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.54 |
| cash per share | 0.85 |
| operating cash flow per share | -0.54 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.27 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -1,823.09 |
Frequently Asked Questions
Coherus BioSciences, Inc. (CHRS) published its most recent earnings results on 06-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Coherus BioSciences, Inc. (NASDAQ:CHRS)'s trailing twelve months ROE is 0.4%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Coherus BioSciences, Inc. (CHRS) currently has a ROA of -0.09%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
CHRS reported a profit margin of -0.15% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.25 in the most recent quarter. The quick ratio stood at 1.09, with a Debt/Eq ratio of -2.63.